• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM Back to Search Results
Model Number 142122-06
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Restenosis (4576)
Date of Event 11/08/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
There was no reported device malfunction and the device was not returned for analysis.A review has been performed of the manufacturing certificate of conformance associated with this lot.There were no non-conformances or deviations which could be associated with this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effect of restenosis leading to intervention is listed in the biomimics 3d instructions for use and is a known patient effect of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available, a follow-up report will be submitted.
 
Event or Problem Description
The patient was treated as part of the mimics 3d usa post-market observational study.On (b)(6) 2022, the patient was treated with one 6.0 x 80mm biomimics 3d (bm3d) stent to treat a denovo lesion of the superficial femoral artery (sfa) middle third to distal third in the right leg.A contralateral approach was used and the lesion was prepared using atherectomy and pre-dilated with percutaneous transluminal angioplasty (pta).The lesion was also post-dilated with pta.The site reported that on (b)(6) 2022, a restenosis of the treated segment (target lesion) was identified.A right distal sfa in-stent restenosis (80-90%) was treated with laser atherectomy and pta/standard balloon angioplasty on 08-nov-22.It was reported as a target lesion revascularisation/target vessel revascularisation (tlr/tvr).There was stenosis of the middle sfa treated with angioplasty, laser atherectomy and stenting.There was also stenosis of the popliteal and tibioperoneal trunk (tpt) treated with angioplasty and laser atherectomy.The restenosis event was reported as not related to the device or procedure but due to a worsening of the patient's pre-existing condition.It was reported as target lesion related.It was reviewed by veryan on 28-nov-22 and considered possibly related to the device.The device remains implanted and the event is reported as resolved/recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Common Device Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Manufacturer (Section D)
VERYAN MEDICAL LTD
unit 11 galway technology park
parkmore road
galway, H91 V E0H
EI  H91 VE0H
Manufacturer Contact
alan mcdonagh
unit 11 galway technology park
parkmore road
galway, H91VE-0H
EI   H91VE0H
MDR Report Key15978964
Report Number3011632150-2022-00120
Device Sequence Number20279923
Product Code NIP
UDI-Device Identifier05391526850428
UDI-Public(01)05391526850428(17)230806(11)220105(10)0000127465
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P180003
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 12/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/06/2023
Device Model Number142122-06
Device Catalogue Number142122-06
Device Lot Number0000127465
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/28/2022
Initial Report FDA Received Date12/14/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured01/05/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ASPIRIN; CLOPIDOGREL (PLAVIX)
Outcome Attributed to Adverse Event Required Intervention;
Patient Age82 YR
Patient SexMale
Patient Weight67 KG
Patient EthnicityHispanic
-
-